Suchergebnisse - "Joy, Mark"

PubPharm (5)

1

Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations : a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales

enthalten in: International journal of epidemiology | 2023

von Kerr, S. | Bedston, S. | Bradley, D. | +13

2

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021 : a national vaccine surveillance platform self-controlled case series study

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2023

von Tsang, R. | Joy, M. | Byford, R. | +18

3

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters : pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

enthalten in: Lancet (London, England) | 2022

von Agrawal, U. | Bedston, S. | McCowan, C. | +24

CommentIn: Lancet. 2022 Oct 15;400(10360):1282-1283. - PMID 36244366

4

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis : A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

enthalten in: PLoS medicine | 2022

von Kerr, S. | Joy, M. | Torabi, F. | +31

CommentIn: PLoS Med. 2022 Feb 22;19(2):e1003948. - PMID 35192620

5

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland : a national prospective cohort study

enthalten in: Lancet (London, England) | 2021

von Vasileiou, E. | Simpson, C. | Shi, T. | +29

CommentIn: Lancet. 2021 May 1;397(10285):1601-1603. - PMID 33901421

1
[1]